HIV Citation List: July 5 - July 18, 2013
PubMed citations
1. Heavy Chain-only IgG2b-llama Antibody Effects Near-pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of Both CD4- and Co-receptor-binding Sites. Acharya, P., T. Luongo, I. Georgiev, J. Matz, S.D. Schmidt, M.K. Louder, P. Kessler, Y. Yang, K. McKee, S. O'Dell, L. Chen, D. Baty, P. Chames, L. Martin, J.R. Mascola, and P.D. Kwong. Journal of Virology, 2013. [Epub ahead of print]. PMID[23843638].
[PubMed]. HIV_0705-071813.
2. Anti-HIV Host Factor SAMHD1 Regulates Viral Sensitivity to Nucleoside Reverse Transcriptase Inhibitors Via Modulation of Cellular Deoxyribonucleoside Triphosphate (dNTP) Levels. Amie, S.M., M.B. Daly, E. Noble, R.F. Schinazi, R.A. Bambara, and B. Kim. The Journal of Biological Chemistry, 2013. 288(28): p. 20683-20691. PMID[23744077].
[PubMed]. HIV_0705-0718.
3. Synthesis and anti-HIV-1 Screening of Novel N'-(1-(Aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[E]pyrazolo[4,3-C][1,2]thiazi N-4(1h)-yl)acetohydrazides.Aslam, S., M. Ahmad, M. Zia-Ur-Rehman, C. Montero, M. Detorio, M. Parvez, and R.F. Schinazi. Archives of Pharmacal Research, 2013. [Epub ahead of print]. PMID[23835833].
[PubMed]. HIV_0705-071813.
4. Transformation of Althaea Officinalis L. By Agrobacterium rhizogenes for the Production of Transgenic Roots Expressing the anti-HIV Microbicide Cyanovirin-N. Drake, P.M., L. de Moraes Madeira, T.H. Szeto, and J.K. Ma. Transgenic Research, 2013. [Epub ahead of print]. PMID[23852261].
[PubMed]. HIV_0705-0718.
5. Dibenzocyclooctane Lignans from the Stems of Schisandra wilsoniana. Ma, W.H., Y. Lu, and D.F. Chen. Planta Medica, 2013. [Epub ahead of print]. PMID[23839820].
[PubMed]. HIV_0705-071813.
6. Synthesis and Antiviral Activity of New Substituted Methyl [2-(Arylmethylene-hydrazino)-4-oxo-thiazolidin-5-ylidene]acetates. Saeed, A., N.A. Al-Masoudi, and M. Latif. Archiv der Pharmazie, 2013. [Epub ahead of print]. PMID[23828482].
[PubMed]. HIV_0705-071813.
7. Preformulation Studies of EFdA, a Novel Nucleoside Reverse Transcriptase Inhibitor for HIV Prevention. Zhang, W., M.A. Parniak, H. Mitsuya, S.G. Sarafianos, P.W. Graebing, and L.C. Rohan. Drug Development and Industrial Pharmacy, 2013. [Epub ahead of print]. PMID[23841536].
[PubMed]. HIV_0705-071813.
8. Molecular Dynamics Study of Carbon Nanotube as a Potential Dual-functional Inhibitor of HIV-1 Integrase. Zhang, Z., B. Wang, B. Wan, L. Yu, and Q. Huang. Biochemical and Biophysical Research Communications, 2013. 436(4): p. 650-654. PMID[23769827].
[PubMed]. HIV_0705-0718.
9. Inhibition of HIV-1 Integrase Dimerization and Activity with Crosslinked Interfacial Peptides. Zhao, L. and J. Chmielewski. Bioorganic & Medicinal Chemistry, 2013. 21(14): p. 4041-4044. PMID[23165001].
[PubMed]. HIV_0705-0718.
ISI Web of Knowledge Citations
10. Curcumin and Its Carbocyclic Analogs: Structure-activity in Relation to Antioxidant and Selected Biological Properties. Bhullar, K.S., A. Jha, D. Youssef, and H.P.V. Rupasinghe. Molecules, 2013. 18(5): p. 5389-5404. ISI[000319446900039].
[WOS]. HIV_0705-071813.
11. Enantioselective Michael Addition of 4-Hydroxycoumarins to Beta,Gamma-unsaturated Alpha-oxophosphonates Catalysed by a Bifunctional Squaramide Bearing a Structurally Rigid 9,10-Ethylene-9,10-dihydroanthracene Skeleton. Chang, X.F., Q.H. Wang, Y.M. Wang, H.B. Song, Z.H. Zhou, and C.C. Tang. European Journal of Organic Chemistry, 2013(11): p. 2164-2171. ISI[000319398600006].
[WOS]. HIV_0705-071813.
12. Evidence in Support of RNA-mediated Inhibition of Phosphatidylserine-dependent HIV-1 Gag Membrane Binding in Cells. Chukkapalli, V., J. Inlora, G.C. Todd, and A. Ono. Journal of Virology, 2013. 87(12): p. 7155-7159. ISI[000319508600057].
[WOS]. HIV_0705-071813.
13. Inhibition of HIV-1 Transcription and Replication by a Newly Identified Cyclin T1 Splice Variant. Gao, G.Z., X.Y. Wu, J.Q. Zhou, M.F. He, J.J. He, and D.Y. Guo. Journal of Biological Chemistry, 2013. 288(20): p. 14297-14309. ISI[000319253500034].
[WOS]. HIV_0705-071813.
14. Scaffold-hopping Strategy toward Calanolides with Nitrogen-containing Heterocycles. Guo, X.Y. and G. Liu. Chinese Chemical Letters, 2013. 24(4): p. 295-298. ISI[000319307900008].
[WOS]. HIV_0705-071813.
15. Induced Degradation of Tat by Nucleocapsid (NC) Via the Proteasome Pathway and Its Effect on HIV Transcription. Hong, H.W., S.W. Lee, and H. Myung. Viruses, 2013. 5(4): p. 1143-1152. ISI[000319437800008].
[WOS]. HIV_0705-071813.
16. Multi-subtype Targeting, Escape-reducing (MuSTER) anti-HIV ShRNA Gene Therapy. Jung, U. and J.J. Rossi. Molecular Therapy, 2013. 21: p. S176-S176. ISI[000319858400455].
[WOS]. HIV_0705-071813.
17. Importance of Polar Solvation and Configurational Entropy for Design of Antiretroviral Drugs Targeting HIV-1 Protease. Kar, P., R. Lipowsky, and V. Knecht. Journal of Physical Chemistry B, 2013. 117(19): p. 5793-5805. ISI[000319649800001].
[WOS]. HIV_0705-071813.
18. Inhibition of Endosome Tubulation with Phospholipase A2 Antagonists Prevents Transport of HIV-1 Across Mucosal Vaginal Epithelial Cells. Kinlock, B., Y.D. Wang, and B.D. Liu. FASEB Journal, 2013. 27. ISI[000319883503398].
[WOS]. HIV_0705-0718.
19. The Effect of Chemical Chaperones on the Assembly and Stability of HIV-1 Capsid Protein. Lampel, A., Y. Bram, M. Levy-Sakin, E. Bacharach, and E. Gazit. PloS one, 2013. 8(4): p. e60867. ISI[000319109800110].
[WOS]. HIV_0705-071813.
20. Two New 3,4;9,10-Seco-cycloartane Type Triterpenoids from Illicium difengpi and Their Anti-inflammatory Activities. Li, C.T., F.M. Xi, J.L. Mi, Z.J. Wu, and W.S. Chen. Evidence-Based Complementary and Alternative Medicine, 2013. ISI[000319611300001].
[WOS]. HIV_0705-071813.
21. Whole Cell-SELEX Derived anti-CD7 Aptamers for the Delivery of anti-CCR5 Sirna: A Prohylactic Approach to HIV Therapy. Millroy, L., D. Lazar, M. Khati, and M.S. Weinberg. Molecular Therapy, 2013. 21: p. S74-S74. ISI[000319858400189].
[WOS]. HIV_0705-071813.
22. Thermodynamic Studies of a Series of Homologous HIV-1 TAR RNA Ligands Reveal That Loose Binders Are Stronger Tat Competitors Than Tight Ones. Pascale, L., S. Azoulay, A. Di Giorgio, L. Zenacker, M. Gaysinski, P. Clayette, and N. Patino. Nucleic Acids Research, 2013. 41(11): p. 5851-5863. ISI[000320116200033].
[WOS]. HIV_0705-0718.
23. Identification and Characterization of a Novel HIV-1 Nucleotide-competing Reverse Transcriptase Inhibitor Series. Rajotte, D., S. Tremblay, A. Pelletier, P. Salois, L. Bourgon, R. Coulombe, S. Mason, L. Lamorte, C.F. Sturino, and R. Bethella. Antimicrobial Agents and Chemotherapy, 2013. 57(6): p. 2712-2718. ISI[000319272100035].
[WOS]. HIV_0705-071813.
24. Poly(ADP-ribose) Polymerase-1 (PARP) Inhibition Decreases HIV-1 Replication in Primary Human Monocyte-Derived Macrophages (MDM). Rom, S., N.L. Reichenbach, and Y. Persidsky. Journal of Neuroimmune Pharmacology, 2013. 8(2): p. 431-432. ISI[000320312000147].
[WOS]. HIV_0705-0718.
25. Inhibition of HIV-1 Transcription by a Tunable Chimeric tRNA(ser)-nucloelar Localizing Trans-activation Response Element (TAR) Decoy. Stevens, C., L. Scherer, J. Rossi, and K. Haushalter. Faseb Journal, 2013. 27. ISI[000319883502050].
[WOS]. HIV_0705-0718.
26. Neamine-heterocycle Conjugates as Potential anti-HIV Agents. Yan, R.B., Y.F. Wu, J. Liu, X.L. Zhang, and X.S. Ye. Chinese Chemical Letters, 2013. 24(4): p. 273-278. ISI[000319307900003].
[WOS]. HIV_0705-071813.